AWH vs. TKNO, VNRX, ABIO, ICCC, OCX, CDIO, TRIB, BMRA, MYMD, and VRAX
Should you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include Alpha Teknova (TKNO), VolitionRx (VNRX), ARCA biopharma (ABIO), ImmuCell (ICCC), OncoCyte (OCX), Cardio Diagnostics (CDIO), Trinity Biotech (TRIB), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), and Virax Biolabs Group (VRAX). These companies are all part of the "diagnostic substances" industry.
Alpha Teknova (NASDAQ:TKNO) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.
13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by insiders. Comparatively, 4.3% of Aspira Women's Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Alpha Teknova presently has a consensus target price of $15.00, suggesting a potential upside of 752.27%. Aspira Women's Health has a consensus target price of $4.45, suggesting a potential upside of 80.16%. Given Aspira Women's Health's higher probable upside, research analysts plainly believe Alpha Teknova is more favorable than Aspira Women's Health.
Alpha Teknova has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.
In the previous week, Alpha Teknova had 1 more articles in the media than Aspira Women's Health. MarketBeat recorded 3 mentions for Alpha Teknova and 2 mentions for Aspira Women's Health. Aspira Women's Health's average media sentiment score of 1.60 beat Alpha Teknova's score of 0.80 indicating that Alpha Teknova is being referred to more favorably in the media.
Aspira Women's Health has lower revenue, but higher earnings than Alpha Teknova. Aspira Women's Health is trading at a lower price-to-earnings ratio than Alpha Teknova, indicating that it is currently the more affordable of the two stocks.
Alpha Teknova has a net margin of -97.85% compared to Alpha Teknova's net margin of -163.95%. Aspira Women's Health's return on equity of -38.24% beat Alpha Teknova's return on equity.
Aspira Women's Health received 6 more outperform votes than Alpha Teknova when rated by MarketBeat users. However, 33.33% of users gave Alpha Teknova an outperform vote while only 26.53% of users gave Aspira Women's Health an outperform vote.
Summary
Alpha Teknova beats Aspira Women's Health on 12 of the 17 factors compared between the two stocks.
Get Aspira Women's Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AWH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aspira Women's Health Competitors List
Related Companies and Tools
